Understanding Liver Enzymes

Evaluation and Credit: https://www.surveymonkey.com/r/MedChat19

 

Target Audience            

This activity is targeted toward Primary care specialties.

Statement of Need

Abnormal liver biochemical and function tests are frequently detected in asymptomatic patients since many screening blood test panels routinely include them. A population-based survey in the United States conducted between 1999 and 2002 estimated that an abnormal alanine aminotransferase (ALT) was present in 8.9 percent of respondents. (2017 article indicated 10% of population have elevated transaminase levels). This podcast will educate providers on preferred approaches to the diagnosis and evaluation of those with abnormal liver tests.

Objectives

At the conclusion of this offering, the participant will be able to:

Discuss liver enzyme testing; screen and diagnostic. Describe diagnostic algorithms for patients with abnormal liver enzyme values. Identify the root causes and underlying conditions of enzyme abnormalities. Discuss the role of O-T-C pain medications and statins on liver enzymes.

 

Moderator

Ryan Nazar, M.D., EMHA

Clinical Effectiveness Director, Quality Management Norton Medical Group

 

Speaker

Ross Deppe, M.D.

Gastroenterologist Norton Gastroenterology Consultants of Louisville

 

Speaker Disclosure

The speaker for this activity has no conflicts of interest to disclose.

Moderator and Planner Disclosures 

The moderator and planners for this activity have no potential or actual conflicts of interest to disclose.

Commercial Support 

This activity has not received commercial support.

 

Continuing Education Credits

 American Medical Association

 

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

 

Designation

Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Kentucky Board of Nursing

Kentucky Board of Nursing (KBN) Approved Provider: Norton Healthcare, provider number 4-0002-12-20-283. The program has been approved by Norton Healthcare for 0.8 contact hours which expires 12/31/2020. KBN approval of a continuing education provider does not constitute endorsement of program content. Nursing participants must attest to the number of hours of attendance and complete the evaluation to receive contact hours.

 

For more information related to nursing credits, contact Sally Sturgeon DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org

 

Date of Original Release | October 2020

Course Termination Date | October 31, 2022  

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org

 

Resources for Additional Study  

Circulating Markers of Liver Function and Cardiovascular Disease Risk

https://pubmed.ncbi.nlm.nih.gov/25977566/

 

Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia

https://pubmed.ncbi.nlm.nih.gov/32077659/

 

Prevalence of Liver Function Test Abnormality and Associated Factors in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study

https://pubmed.ncbi.nlm.nih.gov/31695587/